CLINICAL STUDIES
Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation
Karen L. McNeill*,
Luigi Fontana, MD*,
David L. Russell-Jones, FRCP ,
Iris Rajman, PhD*,
James M. Ritter, FRCP* and
Philip J. Chowienczyk, FRCP*
* Department of Clinical Pharmacology, Centre for Cardiovascular Biology and Medicine, Kings College, London, United Kingdom
Department of Endocrinology and Diabetes, Kings College, London, United Kingdom
Manuscript received August 9, 1999;
revised manuscript received December 7, 1999,
accepted February 2, 2000.
Reprint requests and correspondence: Dr. P. J. Chowienczyk, Department of Clinical Pharmacology, St. Thomas Hospital, Lambeth Palace Road, London, SE1 7EH, United Kingdom phil.chowienczyk{at}kcl.ac.uk
OBJECTIVES
The object of the present study is to determine whether native (n) low-density lipoprotein (LDL) isolated from men with type II diabetes and abnormal endothelial function inhibits endothelium-dependent relaxation more than n-LDL isolated from nondiabetic control subjects.
BACKGROUND
Endothelium-dependent vasodilation is impaired in men with type II diabetes and this may result from qualitative rather than quantitative abnormalities of LDL.
METHODS
Forearm blood flow responses to brachial artery infusions of acetylcholine (endothelium-dependent vasodilator) and nitroprusside (endothelium-independent vasodilator) were measured in 10 men with uncomplicated type II diabetes and 10 nondiabetic men of similar age and with similar plasma concentrations of LDL cholesterol. Native LDL was isolated by discontinuous density gradient ultracentrifugation using EDTA to prevent oxidation. Preconstricted rabbit aortic ring bioassay was used to determine inhibitory properties of n-LDL on endothelium-dependent relaxation by measuring relaxation to acetylcholine (and nitroprusside) in the presence and absence of n-LDL.
RESULTS
Forearm blood flow responses to acetylcholine but not nitroprusside were significantly impaired (p < 0.01) in diabetic men compared with control subjects. Native LDL (10 and 100 µg protein/ml) from diabetic men inhibited relaxation to acetylcholine by 13.9 ± 4.8% and 61.9 ± 7.8% (mean inhibition for all doses ± SE), respectively, whereas n-LDL from control subjects inhibited relaxation by 7.3 ± 3.0% and 23.9 ± 5.7% (p < 0.01 for a difference between diabetic and control n-LDL). Relaxation to nitroprusside was not significantly inhibited by n-LDL.
CONCLUSIONS
A qualitative abnormality of LDL may account for endothelial dysfunction in men with type II diabetes.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | HDL | = high-density lipoprotein | | LDL | = low-density lipoprotein | | n-LDL | = native LDL | | NO | = nitric oxide | | TBARS | = thiobarbituric acidreactive substances |
|
This article has been cited by other articles:

|
 |

|
 |
 
E. Gkaliagkousi, A. Shah, and A. Ferro
Review: Pharmacological and non-pharmacological treatment of endothelial dysfunction: relevance to diabetes
The British Journal of Diabetes & Vascular Disease,
January 1, 2007;
7(1):
5 - 10.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Thomas, P. Chook, M. Qiao, X. S. Huang, H. C. Leong, D. S. Celermajer, and K. S. Woo
Deleterious Impact of "High Normal" Glucose Levels and Other Metabolic Syndrome Components on Arterial Endothelial Function and Intima-Media Thickness in Apparently Healthy Chinese Subjects: The CATHAY Study
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2004;
24(4):
739 - 743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. van Etten, E. J.P. de Koning, M. L. Honing, E. S. Stroes, C. A. Gaillard, and T. J. Rabelink
Intensive Lipid Lowering by Statin Therapy Does Not Improve Vasoreactivity in Patients With Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2002;
22(5):
799 - 804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Chan, H. M. Colhoun, and P. Vallance
Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population
J. Am. Coll. Cardiol.,
December 1, 2001;
38(7):
1814 - 1820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Wendler, P. Landwehr, D. Bandner-Risch, T. Georg, and H.-J. Schafers
Vasoreactivity of arterial grafts in the patient with diabetes mellitus: investigations on internal thoracic artery and radial artery conduits
Eur. J. Cardiothorac. Surg.,
August 1, 2001;
20(2):
305 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|